首页> 外文期刊>Journal of Extracellular Vesicles >Announcing the ISEV2019 special achievement award recipients: Takahiro Ochiya and Marca Wauben
【24h】

Announcing the ISEV2019 special achievement award recipients: Takahiro Ochiya and Marca Wauben

机译:宣布ISEV2019特别成就奖获得者:高O隆弘和Marca Wauben

获取原文
           

摘要

The International Society for Extracellular Vesicles (ISEV) is pleased to announce two Special Achievement Awards that were presented at the ISEV2019 annual meeting in Kyoto, Japan, 24–28 April 2019. ISEV Special Achievement Awards are given each year to one or more individuals who have made outstanding contributions to the field of extracellular vesicle (EV) research or have performed extraordinary service to ISEV. In 2019, ISEV Special Achievement Awards were presented to Professors Takahiro Ochiya, PhD, and Marca Wauben, PhD ( Figure 1 ). 10.1080/20013078.2019.1620080-F0001 Figure 1. ISEV2019 Special Achievement Awards. Awards were presented to Marca Wauben (middle) and Takahiro Ochiya (second from right) by ISEV2019 Chair Hidetoshi Tahara (left), ISEV President Andrew Hill (second from left), and ISEV Chair of Science and Meetings Kenneth Witwer (right). Takahiro Ochiya Takahiro Ochiya has served as Chief of the National Cancer Center Research Institute of Japan and on the council of the Japanese Cancer Association. He has authored more than 300 peer-reviewed publications and holds numerous patents in Japan, the US, and Europe. Dr. Ochiya has been a chief scientist of a program project in Japan, “Development of Diagnostic Technology for Detection of miRNA in Body Fluids,” which is supported by NEDO/AMED. Dr. Ochiya has served as President of the Japanese Society for Extracellular Vesicles (JSEV) as well as in leadership roles in the Japanese Society for RNA Interferences (JARI). In 2018 and 2019, Dr. Ochiya assisted with planning ISEV2019 as a member of the International Organizing Committee. At the meeting, he also delivered a plenary address, entitled “Extracellular Vesicles as Novel Therapeutic Targets in Cancer Metastasis.” For many years, Dr. Ochiya has been at the forefront of microRNA and EV research. Building on numerous contributions to the stem cell and small RNA therapeutics fields [for example [ 1 ]], his group reported in 2010 that EVs mediate the release and uptake of microRNAs (miRNAs) [ 2 ]. In the same year, they also found that miRNAs could be delivered to cancer cells to suppress metastasis [ 3 ]. Dr. Ochiya and his team have probed the mechanisms of EV-mediated microRNA transfer [ 4 ] and have contributed to seminal work on the targeting of EVs to tumor cells [ 5 ]. His group has also been interested in the contributions of milk EVs and extracellular RNA to offspring health [ 6 ]. An ISEV2019 Special Achievement Award was thus presented to Professor Takahiro Ochiya for his “sustained contributions in leading the field in cancer and RNA extracellular biology research and as a mentor to younger researchers.” Marca Wauben Marca Wauben is Professor of Intercellular Communication in the Faculty of Veterinary Medicine at Utrecht University in The Netherlands. She has a long-standing interest in cell-cell interactions via extracellular vesicles, including within the immune system [ 7 – 9 ] and between mother and offspring via breast milk EV proteins and RNAs [ 10 ]. Her group has also made key contributions in the use and standardization of flow cytometry technology for metrology of extracellular vesicles [ 11 – 13 ]. Dr. Wauben’s service to ISEV is also notable. She served on the founding board of ISEV following the 2011 organizing meeting in Paris, was elected to the first ISEV Board of Directors when it was established in 2012, and helped to launch the Journal of Extracellular Vesicles [ 14 ]. As the first ISEV Executive Chair of Science and Meetings, Dr. Wauben was responsible for developing the structure and standard operating procedures of the annual meetings as well as the highly successful ISEV workshop formats, which have led to numerous position papers of ISEV [ 15 – 17 ] that were co-authored by Dr. Wauben. Currently the ISEV Secretary General, Dr. Wauben has also helped to lead various transnational EV networks and is founding president of the Netherlands Society for EVs. In recognition of her extraordinary service to EV science and to ISEV, an ISEV2019 Special Achievement Award was therefore presented to Professor Marca Wauben.
机译:国际细胞外囊泡学会(ISEV)欣然宣布在2019年4月24日至28日在日本京都举行的ISEV2019年度会议上颁发了两项特别成就奖。每年向一个或多个个人颁发ISEV特别成就奖。在细胞外囊泡(EV)研究领域做出了杰出贡献,或者为ISEV做出了杰出贡献。在2019年,ISEV特别成就奖颁给了Takahiro Ochiya教授和Marca Wauben教授(图1)。 10.1080 / 20013078.2019.1620080-F0001图1. ISEV2019特别成就奖。 ISEV2019主席田原英敏(左),ISEV主席安德鲁·希尔(Andrew Hill)(左二)和ISEV科学与会议主席Kenneth Witwer(右)向Marca Wauben(中)和Takahiro Ochiya(右二)颁发了奖项。大chi隆弘(Takahiro Ochiya)高aka隆弘(Takahiro Ochiya)曾担任日本国家癌症中心研究所所长和日本癌症协会理事会理事。他撰写了300余篇经同行评审的出版物,并在日本,美国和欧洲拥有多项专利。 Ochiya博士一直是日本计划项目的首席科学家,该项目由NEDO / AMED支持,“用于检测体液中miRNA的诊断技术的发展”。 Ochiya博士曾担任日本细胞外囊泡学会(JSEV)的主席以及日本RNA干扰学会(JARI)的领导职务。在2018年和2019年,Ochiya博士作为国际组织委员会的成员协助策划了ISEV2019。在会议上,他还作了全体会议题为“细胞外囊泡作为癌症转移的新型治疗靶标”的讲话。多年来,Ochiya博士一直处于microRNA和EV研究的最前沿。基于对干细胞和小RNA治疗领域的众多贡献[例如[1]],他的小组在2010年报道了电动汽车介导了microRNA(miRNA)的释放和摄取[2]。在同一年,他们还发现miRNA可以被传递到癌细胞中以抑制转移[3]。 Ochiya博士及其团队探索了EV介导的microRNA转移的机制[4],并为将EV靶向肿瘤细胞做出了开创性的工作[5]。他的小组还对牛奶电动车和细胞外RNA对子代健康的贡献感兴趣[6]。因其“在领导癌症和RNA细胞外生物学研究领域并为年轻研究者提供指导方面的持续贡献”而获得了ISEV2019特别成就奖。 Marca Wauben Marca Wauben是荷兰乌得勒支大学兽医系细胞间通讯教授。长期以来,她对通过细胞外小泡(包括免疫系统内部)以及母乳和母体之间通过母乳EV蛋白和RNA进行细胞间相互作用的兴趣[10]。她的小组在细胞外囊泡计量学的流式细胞术技术的使用和标准化方面也做出了重要贡献[11-13]。 Wauben博士为ISEV提供的服务也很引人注目。她在巴黎2011年组织会议之后担任ISEV成立董事会,当选为董事的第一ISEV局时,它成立于2012年,并帮助启动杂志外囊泡[14]。作为ISEV的第一位科学和会议执行主席,Wauben博士负责制定年度会议的结构和标准操作程序,以及非常成功的ISEV研讨会形式,这导致了ISEV的众多立场文件[15 – 17]由Wauben博士合着。目前,ISEV秘书长Wauben博士还帮助领导了各种跨国电动汽车网络,并且是荷兰电动汽车协会的创会主席。为了表彰她对电动汽车科学和ISEV的卓越贡献,因此向Marca Wauben教授颁发了ISEV2019特别成就奖。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号